Roche announces data at EHA2021 reinforcing efficacy of Venclexta/Venclyxto combinations in chronic lymphocytic leukaemia and acute myeloid leukaemia

Four-year follow-up analysis from the phase III CLL14 study showed progression-free survival rate of 74.0% in previously untreated patients with chronic lymphocytic leukaemia (CLL) three years after completion of a one-year fixed-duration treatment with Venclexta/Venclyxto plus Gazyva/Gazyvaro1 New phase III MURANO study data suggested certain genetic risk factors may help tailor treatments for patients with... Read more

New Roche data for Evrysdi show improved motor function in pre-symptomatic babies after one year and confirm safety profile in previously treated people with spinal muscular atrophy (SMA)

Data from JEWELFISH, the first trial in a diverse population aged 1 to 60 years with SMA who received prior treatment, showed a consistent safety profile and >2-fold increase in SMN protein levels Pre-symptomatic babies with SMA treated with Evrysdi for at least one year were able to sit, stand and walk in preliminary data... Read more

10x Genomics Unlocks Whole Transcriptome Analysis in FFPE Tissues With New Visium Assay, Now Shipping

June 10, 2021 at 8:01 AM EDTPDF Version Fueling Discovery in Preserved Tissue Samples to Advance Clinical Translational Research PLEASANTON, Calif., June 10, 2021 (GLOBE NEWSWIRE) — 10x Genomics, Inc. (Nasdaq: TXG) today announced it is shipping its new Visium Spatial Gene Expression for FFPE (formalin-fixed and paraffin-embedded) assay. The offering gives researchers access to the... Read more

LGC releases clinical diagnostic quality solution for SARS-CoV-2 variant analysis

LGC’s SeraCare has expanded its line of SARS-CoV-2 molecular quality solutions to include AccuPlex™ SARS-CoV-2 Variant Panel 1. The kit contains full SARS-CoV-2 genomic RNA with a focus on S-gene mutations in three prominent variants of concern (UK variant B.1.1.7, South Africa variant B.1.351, and Brazil variant P.1) with vials for each variant as well as... Read more

Bio-Techne Joins Cell and Gene Therapy Catapult Process Analytical Technology Consortium

JUNE 08, 2021 MINNEAPOLIS, June 8, 2021 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) today announced it is joining the Cell and Gene Therapy Catapult process analytical technology (PAT) consortium, which includes over 20 pharmaceutical companies, technology providers, therapy developers, and charities.  The consortium will assess the application and combination of multiple technologies for process analytics within... Read more

New hard drinking water reference material from NML at LGC traceable to the SI for

The UK’s National Measurement Laboratory (NML), hosted at LGC, is pleased to announce the launch of a new certified reference material, LGC6028 Hard drinking water – metals (lower levels), with values traceable to the SI (International System of Units). The elements present in drinking water are regulated through legislation. These limits ensure the water is safe for... Read more

Thermo Fisher Scientific to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference on June 10, 2021

Thermo Fisher Scientific to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference on June 10, 2021 WALTHAM, Mass., June 8, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present virtually at the Goldman Sachs 42nd Annual... Read more